<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0211-5735</journal-id>
<journal-title><![CDATA[Revista de la Asociación Española de Neuropsiquiatría]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. Asoc. Esp. Neuropsiq.]]></abbrev-journal-title>
<issn>0211-5735</issn>
<publisher>
<publisher-name><![CDATA[Asociación Española de Neuropsiquiatría]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0211-57352018000100181</article-id>
<article-id pub-id-type="doi">10.4321/s0211-57352018000100010</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Un enfoque alternativo del tratamiento farmacológico en psiquiatría]]></article-title>
<article-title xml:lang="en"><![CDATA[An alternative approach to drug treatment in psychiatry]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Moncrieff]]></surname>
<given-names><![CDATA[Joanna]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,University College London Division of Psychiatry ]]></institution>
<addr-line><![CDATA[Londres ]]></addr-line>
<country>Reino Unido</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>06</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>06</month>
<year>2018</year>
</pub-date>
<volume>38</volume>
<numero>133</numero>
<fpage>181</fpage>
<lpage>193</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_arttext&amp;pid=S0211-57352018000100181&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_abstract&amp;pid=S0211-57352018000100181&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_pdf&amp;pid=S0211-57352018000100181&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen: Aunque habitualmente se piensa que la actividad beneficiosa de los psicofármacos tiene que ver con la capacidad de estos para contrarrestar las condiciones biológicas que subyacen a los síntomas de los trastornos mentales, las pruebas que apoyan esta perspectiva son pequeñas y claramente insuficientes. Pudiera ser que los efectos beneficiosos se deban a las propiedades psicoactivas de los psicofármacos, al provocar estados mentales alterados en las personas que los toman, quienes pueden considerar esos estados más deseables que el sufrimiento mental original. Tener en cuenta este enfoque alternativo del tratamiento farmacológico en psiquiatría puede tener consecuencias significativas a la hora de proponer su uso, informar de sus efectos, prescribirlos a corto y largo plazo, y orientar la investigación necesaria para determinar los riesgos y beneficios de su uso.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract: Although it is commonly believed that the benefits of psychiatric drugs are related to their capacity to compensate the underlying biology of mental disorders, the evidence supporting this perspective is poor and clearly insufficient. These beneficial effects may be due to the psychoactive properties of psychotropic drugs, which cause altered mental states that people who take them might consider a preferred option, rather than the original mental suffering. Considering this alternative approach could have significant consequences in psychiatry when proposing their use, reporting their effects, prescribing them in the short and long term, and guiding the research needed to determine the risks and benefits of their use.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[modelos de acción farmacológica]]></kwd>
<kwd lng="es"><![CDATA[psicofármacos]]></kwd>
<kwd lng="es"><![CDATA[fármacos psicoactivos]]></kwd>
<kwd lng="es"><![CDATA[modelo centrado en el fármaco]]></kwd>
<kwd lng="es"><![CDATA[modelo centrado en la enfermedad]]></kwd>
<kwd lng="en"><![CDATA[models of drug action]]></kwd>
<kwd lng="en"><![CDATA[psychiatric drugs]]></kwd>
<kwd lng="en"><![CDATA[psychoactive drugs]]></kwd>
<kwd lng="en"><![CDATA[drug-centred model]]></kwd>
<kwd lng="en"><![CDATA[disease-centred model]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hyman]]></surname>
<given-names><![CDATA[SE]]></given-names>
</name>
<name>
<surname><![CDATA[Nestler]]></surname>
<given-names><![CDATA[EJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Initiation and adaptation: a paradigm for understanding psychotropic drug action]]></article-title>
<source><![CDATA[Am J Psychiatry]]></source>
<year>1996</year>
<volume>153</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>151-62</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Eli]]></surname>
<given-names><![CDATA[Lilly]]></given-names>
</name>
</person-group>
<source><![CDATA[Zyprexa website]]></source>
<year>2006</year>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="book">
<collab>Royal College of Psychiatrists</collab>
<source><![CDATA[Antidepressants]]></source>
<year>2009</year>
<publisher-loc><![CDATA[London ]]></publisher-loc>
<publisher-name><![CDATA[Royal College of Psychiatrists]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="">
<collab>American Psychiatric Association</collab>
<source><![CDATA[Let's talk facts about depression]]></source>
<year>2005</year>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Moncrieff]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<source><![CDATA[The myth of the chemical cure: a critique of psychiatric drug treatment]]></source>
<year>2008</year>
<publisher-loc><![CDATA[Basingstoke, Hampshire, UK ]]></publisher-loc>
<publisher-name><![CDATA[Palgrave Macmillan]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Moncrieff]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Cohen]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Rethinking models of psychotropic drug action]]></article-title>
<source><![CDATA[Psychother Psychosom]]></source>
<year>2005</year>
<volume>74</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>145-53</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Moncrieff]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A critique of the dopamine hypothesis of schizophrenia and psychosis]]></article-title>
<source><![CDATA[Harv Rev Psychiatry]]></source>
<year>2009</year>
<volume>17</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>214-25</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kendler]]></surname>
<given-names><![CDATA[KS]]></given-names>
</name>
<name>
<surname><![CDATA[Schaffner]]></surname>
<given-names><![CDATA[KF]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The dopamine hypothesis of schizophrenia: an historical and philosophical analysis]]></article-title>
<source><![CDATA[Philos Psychiatr Psychol]]></source>
<year>2011</year>
<volume>18</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>41-63</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Moncrieff]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Cohen]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Do antidepressants cure or create abnormal brain states?]]></article-title>
<source><![CDATA[PLoS Med]]></source>
<year>2006</year>
<volume>3</volume>
<numero>7</numero>
<issue>7</issue>
</nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Murphy]]></surname>
<given-names><![CDATA[FC]]></given-names>
</name>
<name>
<surname><![CDATA[Smith]]></surname>
<given-names><![CDATA[KA]]></given-names>
</name>
<name>
<surname><![CDATA[Cowen]]></surname>
<given-names><![CDATA[PJ]]></given-names>
</name>
<name>
<surname><![CDATA[Robbins]]></surname>
<given-names><![CDATA[TW]]></given-names>
</name>
<name>
<surname><![CDATA[Sahakian]]></surname>
<given-names><![CDATA[BJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The effects of tryptophan depletion on cognitive and affective processing in healthy volunteers]]></article-title>
<source><![CDATA[Psychopharmacology (Berl)]]></source>
<year>2002</year>
<volume>163</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>42-53</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dubovsky]]></surname>
<given-names><![CDATA[SL]]></given-names>
</name>
<name>
<surname><![CDATA[Davies]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Dubovsky]]></surname>
<given-names><![CDATA[AN]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Mood disorders]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Hales]]></surname>
<given-names><![CDATA[RE]]></given-names>
</name>
<name>
<surname><![CDATA[Yudofsky]]></surname>
<given-names><![CDATA[SC]]></given-names>
</name>
</person-group>
<source><![CDATA[Textbook of Clinical Psychiatry]]></source>
<year>2001</year>
<publisher-loc><![CDATA[Washington ]]></publisher-loc>
<publisher-name><![CDATA[American Psychiatric Association]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Stahl]]></surname>
<given-names><![CDATA[SM]]></given-names>
</name>
</person-group>
<source><![CDATA[Stahl's Essential Psychopharmacology]]></source>
<year>2013</year>
<edition>4th Edition</edition>
<publisher-loc><![CDATA[Cambridge ]]></publisher-loc>
<publisher-name><![CDATA[Cambridge University Press]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Robertson]]></surname>
<given-names><![CDATA[MM]]></given-names>
</name>
<name>
<surname><![CDATA[Trimble]]></surname>
<given-names><![CDATA[MR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Major tranquillisers used as antidepressants. A review]]></article-title>
<source><![CDATA[J Affect Disord]]></source>
<year>1982</year>
<volume>4</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>173-93</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Moncrieff]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Are antidepressants overrated? A review of methodological problems in antidepressant trials]]></article-title>
<source><![CDATA[J Nerv Ment Dis]]></source>
<year>2001</year>
<volume>189</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>288-95</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Casey]]></surname>
<given-names><![CDATA[JF]]></given-names>
</name>
<name>
<surname><![CDATA[Lasky]]></surname>
<given-names><![CDATA[JJ]]></given-names>
</name>
<name>
<surname><![CDATA[Klett]]></surname>
<given-names><![CDATA[CJ]]></given-names>
</name>
<name>
<surname><![CDATA[Hollister]]></surname>
<given-names><![CDATA[LE]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Treatment of schizophrenic reactions with phenothiazine derivatives. A comparative study of chlorpromazine, triflupromazine, mepazine, prochlorperazine, perphenazine, and phenobarbital]]></article-title>
<source><![CDATA[Am J Psychiatry]]></source>
<year>1960</year>
<volume>117</volume>
<page-range>97-105</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Casey]]></surname>
<given-names><![CDATA[JF]]></given-names>
</name>
<name>
<surname><![CDATA[Bennett]]></surname>
<given-names><![CDATA[IF]]></given-names>
</name>
<name>
<surname><![CDATA[Lindley]]></surname>
<given-names><![CDATA[CJ]]></given-names>
</name>
<name>
<surname><![CDATA[Hollister]]></surname>
<given-names><![CDATA[LE]]></given-names>
</name>
<name>
<surname><![CDATA[Gordon]]></surname>
<given-names><![CDATA[MH]]></given-names>
</name>
<name>
<surname><![CDATA[Springer]]></surname>
<given-names><![CDATA[NN]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Drug therapy in schizophrenia. A controlled study of the relative effectiveness of chlorpromazine, promazine, phenobarbital, and placebo]]></article-title>
<source><![CDATA[AMA Arch Gen Psychiatry]]></source>
<year>1960</year>
<volume>2</volume>
<page-range>210-20</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wolkowitz]]></surname>
<given-names><![CDATA[OM]]></given-names>
</name>
<name>
<surname><![CDATA[Pickar]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Benzodiazepines in the treatment of schizophrenia: a review and reappraisal]]></article-title>
<source><![CDATA[Am J Psychiatry]]></source>
<year>1991</year>
<volume>148</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>714-26</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Abse]]></surname>
<given-names><![CDATA[DW]]></given-names>
</name>
<name>
<surname><![CDATA[Dahlstrom]]></surname>
<given-names><![CDATA[WG]]></given-names>
</name>
<name>
<surname><![CDATA[Tolley]]></surname>
<given-names><![CDATA[AG]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evaluation of tranquilizing drugs in the management of acute mental disturbance]]></article-title>
<source><![CDATA[Am J Psychiatry]]></source>
<year>1960</year>
<volume>116</volume>
<page-range>973-80</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Judd]]></surname>
<given-names><![CDATA[LL]]></given-names>
</name>
<name>
<surname><![CDATA[Hubbard]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Janowsky]]></surname>
<given-names><![CDATA[DS]]></given-names>
</name>
<name>
<surname><![CDATA[Huey]]></surname>
<given-names><![CDATA[LY]]></given-names>
</name>
<name>
<surname><![CDATA[Takahashi]]></surname>
<given-names><![CDATA[KI]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The effect of lithium carbonate on the cognitive functions of normal subjects]]></article-title>
<source><![CDATA[Arch Gen Psychiatry]]></source>
<year>1977</year>
<volume>34</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>355-7</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Judd]]></surname>
<given-names><![CDATA[LL]]></given-names>
</name>
<name>
<surname><![CDATA[Hubbard]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Janowsky]]></surname>
<given-names><![CDATA[DS]]></given-names>
</name>
<name>
<surname><![CDATA[Huey]]></surname>
<given-names><![CDATA[LY]]></given-names>
</name>
<name>
<surname><![CDATA[Attewell]]></surname>
<given-names><![CDATA[PA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The effect of lithium carbonate on affect, mood, and personality of normal subjects]]></article-title>
<source><![CDATA[Arch Gen Psychiatry]]></source>
<year>1977</year>
<volume>34</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>346-51</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Braden]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Fink]]></surname>
<given-names><![CDATA[EB]]></given-names>
</name>
<name>
<surname><![CDATA[Qualls]]></surname>
<given-names><![CDATA[CB]]></given-names>
</name>
<name>
<surname><![CDATA[Ho]]></surname>
<given-names><![CDATA[CK]]></given-names>
</name>
<name>
<surname><![CDATA[Samuels]]></surname>
<given-names><![CDATA[WO]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Lithium and chlorpromazine in psychotic inpatients]]></article-title>
<source><![CDATA[Psychiatry Res]]></source>
<year>1982</year>
<volume>7</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>69-81</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chouinard]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The use of benzodiazepines in the treatment of manic-depressive illness]]></article-title>
<source><![CDATA[J Clin Psychiatry]]></source>
<year>1988</year>
<volume>49</volume>
<numero>^sSuppl</numero>
<issue>^sSuppl</issue>
<supplement>Suppl</supplement>
<page-range>15-20</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Johnstone]]></surname>
<given-names><![CDATA[EC]]></given-names>
</name>
<name>
<surname><![CDATA[Crow]]></surname>
<given-names><![CDATA[TJ]]></given-names>
</name>
<name>
<surname><![CDATA[Frith]]></surname>
<given-names><![CDATA[CD]]></given-names>
</name>
<name>
<surname><![CDATA[Owens]]></surname>
<given-names><![CDATA[DG]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The Northwick Park &#8220;functional&#8221; psychosis study: diagnosis and treatment response]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>1988</year>
<volume>2</volume>
<numero>8603</numero>
<issue>8603</issue>
<page-range>119-25</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Prien]]></surname>
<given-names><![CDATA[RF]]></given-names>
</name>
<name>
<surname><![CDATA[EM]]></surname>
<given-names><![CDATA[Jr]]></given-names>
</name>
<name>
<surname><![CDATA[Klett]]></surname>
<given-names><![CDATA[CJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Comparison of lithium carbonate and chlorpromazine in the treatment of mania. Report of the Veterans Administration and National Institute of Mental Health Collaborative Study Group]]></article-title>
<source><![CDATA[Arch Gen Psychiatry]]></source>
<year>1972</year>
<volume>26</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>146-53</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bourin]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Fiocco]]></surname>
<given-names><![CDATA[AJ]]></given-names>
</name>
<name>
<surname><![CDATA[Clenet]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[How valuable are animal models in defining antidepressant activity?]]></article-title>
<source><![CDATA[Hum Psychopharmacol]]></source>
<year>2001</year>
<volume>16</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>9-21</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Berridge]]></surname>
<given-names><![CDATA[CW]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Neural substrates of psychostimulant-induced arousal]]></article-title>
<source><![CDATA[Neuropsychopharmacology]]></source>
<year>2006</year>
<volume>31</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>2332-40</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tschanz]]></surname>
<given-names><![CDATA[JT]]></given-names>
</name>
<name>
<surname><![CDATA[Rebec]]></surname>
<given-names><![CDATA[GV]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Atypical antipsychotic drugs block selective components of amphetamine-induced stereotypy]]></article-title>
<source><![CDATA[Pharmacol Biochem Behav]]></source>
<year>1988</year>
<volume>31</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>519-22</page-range></nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Moncrieff]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Cohen]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Mason]]></surname>
<given-names><![CDATA[JP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The subjective experience of taking antipsychotic medication: a content analysis of Internet data]]></article-title>
<source><![CDATA[Acta Psychiatr Scand]]></source>
<year>2009</year>
<volume>120</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>102-11</page-range></nlm-citation>
</ref>
<ref id="B29">
<label>29</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Breggin]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<source><![CDATA[Brain-disabling treatments in psychiatry]]></source>
<year>2008</year>
<edition>2nd ed.</edition>
<publisher-loc><![CDATA[New York ]]></publisher-loc>
<publisher-name><![CDATA[Springer Publishing Company]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B30">
<label>30</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mizrahi]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Bagby]]></surname>
<given-names><![CDATA[RM]]></given-names>
</name>
<name>
<surname><![CDATA[Zipursky]]></surname>
<given-names><![CDATA[RB]]></given-names>
</name>
<name>
<surname><![CDATA[Kapur]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[How antipsychotics work: the patients' perspective]]></article-title>
<source><![CDATA[Prog Neuropsychopharmacol Biol Psychiatry]]></source>
<year>2005</year>
<volume>29</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>859-64</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
